Nature Communications (Jul 2022)
Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
- Sushil Kumar,
- Ajeya Nandi,
- Snahlata Singh,
- Rohan Regulapati,
- Ning Li,
- John W. Tobias,
- Christian W. Siebel,
- Mario Andres Blanco,
- Andres J. Klein-Szanto,
- Christopher Lengner,
- Alana L. Welm,
- Yibin Kang,
- Rumela Chakrabarti
Affiliations
- Sushil Kumar
- Department of Biomedical Sciences, University of Pennsylvania
- Ajeya Nandi
- Department of Biomedical Sciences, University of Pennsylvania
- Snahlata Singh
- Department of Biomedical Sciences, University of Pennsylvania
- Rohan Regulapati
- Department of Biomedical Sciences, University of Pennsylvania
- Ning Li
- Department of Biomedical Sciences, University of Pennsylvania
- John W. Tobias
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania
- Christian W. Siebel
- Department of Discovery Oncology, Genentech Inc.
- Mario Andres Blanco
- Department of Biomedical Sciences, University of Pennsylvania
- Andres J. Klein-Szanto
- Histopathology Facility, Fox Chase Cancer Center
- Christopher Lengner
- Department of Biomedical Sciences, University of Pennsylvania
- Alana L. Welm
- Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah
- Yibin Kang
- Department of Molecular Biology, Princeton University
- Rumela Chakrabarti
- Department of Biomedical Sciences, University of Pennsylvania
- DOI
- https://doi.org/10.1038/s41467-022-30946-9
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 2
Abstract
No abstracts available.
